Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 598)
Posted On: 09/30/2019 5:35:15 PM
Post# of 153905
Posted By: LACYDY
Re: lorbas #9024
The science is already confirmed...multiple times over by now. BTD would not doing much to confirm a science that has already been proven by many.

I don't quite understand why everyone is so anxious about Breakthrough Therapy Designation. We have already submitted p1 of BLA and within months of submitting p2/3 of BLA. BTD is typically meant for pharma's to apply for before initiation of Phase 3 or at least at very beginning of clinical trials before interim data. There is little benefit for BTD at this time. If it takes up to 2 months for FDA to review our request for BTD, and it will be Oct. 1 tomorrow, and we plan on submitting for BLA by end of Nov or Dec, why would we waste time on that instead of focusing on BLA exclusively? Not to mention we had already applied for BTD 1 time for sure, and possibly a 2nd time if I remember correctly, and FDA denied us BTD for HIV combo.

If anything we should be applying for Priority Review to expedite the approval date.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site